Clinical Trial Update: Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for probiotic therapy aimed at eradicating carbapenem-resistant Klebsiella pneumoniae in Phase 1/Phase 2. The status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Klebsiella Pneumoniae Infection

Drugs mentioned

• Probiotic therapy

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Anti-Biotic Resistance, Klebsiella Pneumoniae | Phase 1, Phase 2 | Status: UNKNOWN